Valuation: Cogstate Limited

Market Cap 430M 300M 264M 245M 225M 422M 28.96B 2.91B 1.14B 14.21B 1.13B 1.1B 49.16B P/E 2026 *
25.7x
P/E 2027 * 18.9x
Enterprise Value 373M 260M 229M 213M 195M 366M 25.11B 2.53B 987M 12.32B 976M 955M 42.62B EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.5x
Free-Float
54.18%
Yield 2026 *
1.29%
Yield 2027 * 1.62%

Last Transcript: Cogstate Limited

1 day-1.94%
1 week-7.33%
Current month-7.33%
1 month-8.00%
3 months+3.69%
6 months+12.44%
Current year+11.95%
1 week 2.52
Extreme 2.52
2.77
1 month 2.52
Extreme 2.52
3.01
Current year 2.01
Extreme 2.01
3.01
1 year 1.55
Extreme 1.55
3.01
3 years 0.8
Extreme 0.795
3.01
5 years 0.8
Extreme 0.795
3.01
10 years 0.16
Extreme 0.155
3.01
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap.
5/20/26 Buy

Director

3,600 0.0021%
5/20/26 Buy

Director

430 0.0003%
4/15/26
Myer & Myer Pty Ltd.
BuyCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-1.94%-7.33%+41.34%+75.09% 301M
+1.07%-3.49%-3.25%+12.87% 46.86B
+0.25%+1.65%+399.22%+634.87% 40.23B
-0.27%+4.45%+11.81%+65.64% 36.23B
+0.35%+0.87%+4.46%-10.16% 34.72B
+3.14%+1.02%+3.37%+38.15% 27.89B
-0.73%+11.84%+34.39%+134.36% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%-3.43%+9.03% 13.12B
-2.68%-2.49%-11.36%-33.61% 12.7B
Average +0.01%+0.01%+52.95%+102.92% 24.56B
Weighted average by Cap. +0.48%+0.90%+74.22%+136.35%

Financials

2026 *2027 *
Net sales 86.95M 60.68M 53.39M 49.6M 45.52M 85.47M 5.86B 590M 230M 2.87B 228M 223M 9.94B 102M 71.36M 62.79M 58.33M 53.53M 101M 6.89B 693M 271M 3.38B 268M 262M 11.7B
Net income 16.9M 11.79M 10.38M 9.64M 8.85M 16.61M 1.14B 115M 44.75M 559M 44.27M 43.32M 1.93B 22.92M 16M 14.07M 13.08M 12M 22.53M 1.54B 155M 60.7M 758M 60.05M 58.76M 2.62B
Net Debt -57.17M -39.9M -35.1M -32.61M -29.93M -56.2M -3.85B -388M -151M -1.89B -150M -147M -6.54B -72.31M -50.47M -44.4M -41.25M -37.85M -71.08M -4.87B -490M -191M -2.39B -189M -185M -8.27B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-07-24 A$2.530 -1.94% 68,392
26-07-23 A$2.580 -1.90% 173,698
26-07-22 A$2.630 -2.95% 135,327
26-07-21 A$2.710 -1.45% 191,697
26-07-20 A$2.750 +0.73% 184,153
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.530AUD
Average target price
3.540AUD
Spread / Average Target
+39.92%

Quarterly revenue - Rate of surprise